Editorial Staff
NewsWriter.ai
@editorial-staff
Newswriter.ai is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
23607 articles
Articles
Roth Capital Schedules Extensive Investor Conference Calendar Through June 2027
Roth Capital Partners has announced a series of investor events spanning healthcare, nuclear technology, solar, and other growth sectors, signaling continued focus on emerging industries.
September 8, 2026Read the full article
Wearable Devices to Showcase Neural Sensing for Physical AI and Humanoid Robotics at Tel Aviv Event
Wearable Devices Ltd. will present its neural sensing technology for Physical AI and humanoid robotics, potentially advancing how machines learn from human movement and intent.
September 8, 2026Read the full article
Faraday Future Showcases Robotics and AI Strategy at Moody Capital Conference
Faraday Future Intelligent Electric Inc. highlights its Physical AI ecosystem and robotics initiatives at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference, signaling a strategic pivot towards embodied AI.
September 8, 2026Read the full article
Frontieras North America Offers Domestic Energy Solution Amid Geopolitical Disruption
As geopolitical tensions highlight the risks of imported energy, Frontieras North America is advancing a coal-to-products infrastructure to bolster U.S. energy independence.
September 8, 2026Read the full article
Cyabra Showcases AI-Powered Narrative Intelligence at Moody Capital Conference
Cyabra's participation in the Moody Capital 2026 Disruptive Growth & Life Sciences Conference highlights its AI-driven tools that combat disinformation, offering significant implications for national security, corporate trust, and digital integrity.
September 8, 2026Read the full article
Laser Therapy Advances Offer New Hope for Brain Cancer Patients
Researchers at Washington University School of Medicine have refined laser interstitial thermal therapy (LITT), a minimally invasive laser treatment for brain cancer, potentially improving outcomes and patient experiences.
September 8, 2026Read the full article
Impala Platinum's Dividend Payout Signals Strong PGM Market Recovery
Impala Platinum's enhanced dividends highlight a rebound in PGM prices, prompting analysts to watch how other producers like Platinum Group Metals allocate their earnings.
September 8, 2026Read the full article
Quantum BioPharma Gets FDA Clearance for First-in-Class MS Drug Trial
Quantum BioPharma's FDA clearance to test Lucid-MS in phase 2 trials marks a potential breakthrough in multiple sclerosis treatment by targeting myelin repair, not just immune suppression.
September 8, 2026Read the full article
OS Animal Health Highlights Canine Cancer Immunotherapy at Disruptive Growth & Life Sciences Conference
OS Animal Health's presentation at the Moody Capital conference underscores its push to advance OST-HER2 for canine osteosarcoma, potentially reshaping veterinary oncology and signaling growth in the pet cancer treatment market.
September 8, 2026Read the full article
Musk and Zuckerberg Urge G20 to Boost Data Center Infrastructure for AI
Elon Musk and Mark Zuckerberg called on G20 nations to accelerate data center expansion to support AI growth, a move with significant implications for the tech industry and global digital infrastructure.
September 8, 2026Read the full article
Ocumetics Advances to Group Two Clinical Trials for Next-Generation Intraocular Lens
Ocumetics Technology Corp. begins patient recruitment for Group Two human clinical surgeries of its accommodating intraocular lens, aiming to evaluate safety and vision performance, marking a step toward potentially eliminating corrective lenses.
September 8, 2026Read the full article
Quantum BioPharma Gets FDA Clearance for First-in-Class MS Drug Targeting Myelin Repair
Quantum BioPharma's FDA clearance to test Lucid-MS in phase 2 trials marks a potential breakthrough in multiple sclerosis treatment by targeting myelin repair, offering hope for millions.
September 8, 2026Read the full article
NanoViricides Registers Phase II Ebola Trial for NV-387 Oral Gummies in DRC
NanoViricides has registered a Phase II clinical trial for its broad-spectrum antiviral NV-387 as a treatment for Ebola in the Democratic Republic of Congo, marking a significant step in addressing deadly viral outbreaks.
September 8, 2026Read the full article
Datavault AI Sets Sept. 15 Launch for Three Data Exchange Platforms
Datavault AI will launch its IDE, NIL Vault, and APEX platforms on Sept. 15, marking a shift to commercial deployment with implications for data monetization and tokenization.
September 8, 2026Read the full article
LaFleur Minerals Advances Toward Near-Term Gold Production at Fully Permitted Beacon Mill
LaFleur Minerals is set to transition from recommissioning to gold production at its fully permitted Beacon Gold Mill, leveraging nearby resources to become a near-term producer in the Abitibi Gold Belt.
September 8, 2026Read the full article
Nutriband Secures Trademark Milestone for Abuse-Deterrent Fentanyl Patch
Nutriband advances trademark protection for its abuse-deterrent fentanyl patch, a key step toward commercialization of a product with significant market potential.
September 8, 2026Read the full article
Greenland Mines Sets Q4 Biotech Spin-Off, Advances Sarfartoq Rare Earths Project
Greenland Mines announced a Q4 2026 biotech spin-off and strategic shift to critical minerals, with a Nasdaq listing compliance resolution and a high-value Sarfartoq project assessment.
September 8, 2026Read the full article
tZERO to Power Archax Markets' U.S. Expansion with Regulated Digital Securities Infrastructure
tZERO's correspondent clearing relationship with Archax Markets will provide regulated infrastructure for the latter's U.S. digital securities offering, expanding institutional access to tokenized assets.
September 8, 2026Read the full article
Quantum BioPharma Gains FDA Clearance for Phase 2 Multiple Sclerosis Trial of Lucid-MS
Quantum BioPharma has received FDA clearance to begin a Phase 2 trial of its novel multiple sclerosis drug candidate Lucid-MS, marking a significant step forward in developing a non-immunosuppressive treatment for the disease.
September 8, 2026Read the full article
New Study Ranks Home Service Training Providers by Specific Business Needs, Not Overall Winner
DataTurk.ai's 2026 Home Service Training & Coaching Study compares six major training organizations across eight categories, revealing that the best provider depends on a contractor's specific business problem.
September 8, 2026Read the full article
Quantum BioPharma Gains FDA Clearance for Phase 2 Trial of Lucid-MS in Multiple Sclerosis
Quantum BioPharma received FDA clearance to initiate a Phase 2 trial of its first-in-class drug Lucid-MS for multiple sclerosis, a significant step toward a targeted therapy that could shift treatment paradigms.
September 8, 2026Read the full article